BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 20 filers reported holding BIONTECH SE in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $59,369,044 | -6.2% | 546,475 | -6.8% | 0.04% | +11.8% |
Q2 2023 | $63,275,151 | -18.1% | 586,261 | -5.4% | 0.03% | -20.9% |
Q1 2023 | $77,215,711 | -15.5% | 619,858 | +1.9% | 0.04% | -18.9% |
Q4 2022 | $91,422,691 | +4.5% | 608,592 | -6.1% | 0.05% | 0.0% |
Q3 2022 | $87,444,000 | -9.8% | 648,319 | -0.3% | 0.05% | -1.9% |
Q2 2022 | $96,992,000 | +9.4% | 650,520 | +25.2% | 0.05% | +31.7% |
Q1 2022 | $88,639,000 | -44.7% | 519,696 | -16.4% | 0.04% | -43.1% |
Q4 2021 | $160,335,000 | +114.6% | 621,933 | +127.2% | 0.07% | +105.7% |
Q3 2021 | $74,715,000 | -17.4% | 273,690 | -32.3% | 0.04% | -20.5% |
Q2 2021 | $90,474,000 | +94.4% | 404,115 | -5.2% | 0.04% | +76.0% |
Q1 2021 | $46,540,000 | +349.9% | 426,226 | +235.9% | 0.02% | +316.7% |
Q4 2020 | $10,344,000 | -70.1% | 126,894 | -74.6% | 0.01% | -75.0% |
Q3 2020 | $34,591,000 | -1.3% | 499,649 | -4.8% | 0.02% | -11.1% |
Q2 2020 | $35,043,000 | +2137.7% | 525,075 | +1858.1% | 0.03% | +2600.0% |
Q1 2020 | $1,566,000 | +32.2% | 26,815 | -23.4% | 0.00% | 0.0% |
Q4 2019 | $1,185,000 | – | 35,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fosun International Ltd | 1,053,640 | $179,709,000 | 15.52% |
Bill & Melinda Gates Foundation | 148,674 | $25,400,000 | 13.66% |
Baader Bank Aktiengesellschaft | 224,800 | $38,342,000 | 3.07% |
Quinn Opportunity Partners LLC | 402,239 | $68,606,000 | 2.96% |
Pendal Group Ltd | 1,957,594 | $333,887,000 | 2.75% |
Boston Common Asset Management, LLC | 280,181 | $47,788,000 | 2.06% |
Tri Locum Partners LP | 30,923 | $5,274,000 | 2.06% |
Renaissance Capital LLC | 25,267 | $4,310,000 | 1.83% |
Robbins Farley | 13,220 | $2,255,000 | 1.70% |
APEIRON CAPITAL Ltd | 21,300 | $3,633,000 | 1.61% |